- Investing Ideas
- U.S. Healthcare Undervalued based on future growth
U.S. Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
CONMED
Market Cap: US$1.3b
A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
CNMD
US$43.21
7D
2.9%
1Y
-13.8%
Nutex Health
Market Cap: US$1.0b
Operates as a healthcare services and operations company in the United States.
NUTX
US$140.25
7D
-10.8%
1Y
67.0%
GMR Solutions
Market Cap: US$1.0b
Operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States.
GMRS
US$12.93
7D
1.0%
1Y
n/a
Auna
Market Cap: US$384.9m
A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.
AUNA
US$5.20
7D
3.6%
1Y
-15.3%
OptimizeRx
Market Cap: US$119.0m
Operates as a digital healthcare technology company.
OPRX
US$6.37
7D
-1.5%
1Y
-49.6%
CareCloud
Market Cap: US$100.3m
A healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.
CCLD
US$2.42
7D
10.5%
1Y
2.5%
Xtant Medical Holdings
Market Cap: US$59.7m
Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
XTNT
US$0.43
7D
-1.1%
1Y
-28.7%